Chalayer, E., Daguenet, E., Bobin, A., Fatrara, T., Bounouara, I., Noël, S., Garnier, K., Karlin, L., Touzeau, C., Decaux, O., Hulin, C., Chalopin, T., Macro, M., Dib, M., Tiab, M., Dingremont, C., Godmer, P., Montes, L., Vidal, V., Labarthe, A., Fleck, E., Vincent, L., Blade, J., Waultier-Rascalou, A., Gay, J., Roussel, M., Piocelle, F. O., Frenzel, L., Moreau, P., Manier, S., Perrot, A., Leleu, X., Delavenne, X. (2025). Apixaban pharmacokinetics in newly diagnosed multiple myeloma patients treated in the benefit and isasocut clinical trials: The apixabor/mibapix study. Blood. https://doi.org/10.1182/blood-2025-744